2021
DOI: 10.12998/wjcc.v9.i18.4866
|View full text |Cite
|
Sign up to set email alerts
|

Adult rhabdomyosarcoma originating in the temporal muscle, invading the skull and meninges: A case report

Abstract: BACKGROUND Rhabdomyosarcoma (RMS) is a rare malignant tumor of mesenchymal origin that mainly affects children. Spindle cell/sclerosing RMS (SSRMS) is even rarer. It is a new subtype that was added to the World Health Organization disease classification in 2013. To the best of our knowledge, this is the first reported case of adult SSRMS disease classification originating in the temporal muscle. CASE SUMMARY SSRMS originating in the temporal muscle of a male adult enlar… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 23 publications
0
2
0
Order By: Relevance
“…Whereas, SS-RMS mainly occurs in infants, children, and adults that similar to ES-RMS and has a median age about 24 years, which affects even younger people than E-RMS. But both E-RMS and SS-RMS mainly arises from the head and neck, and extremity [ 10 , 22 47 ] (Tables 2 and 3 ).…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Whereas, SS-RMS mainly occurs in infants, children, and adults that similar to ES-RMS and has a median age about 24 years, which affects even younger people than E-RMS. But both E-RMS and SS-RMS mainly arises from the head and neck, and extremity [ 10 , 22 47 ] (Tables 2 and 3 ).…”
Section: Resultsmentioning
confidence: 99%
“…Additionally, we found that many cases of ES-RMS had local progression or metastasis, and up to 50% (12/24) of ES-RMS had died of disease within the follow-up times, similar to E-RMS (median survival time is 10 month) [ 22 32 ], ES-RMS showed a more aggressive behavior and adverse prognosis (median survival time is 17 month) than SS-RMS (median survival time is 65 month) [ 10 , 12 , 15 17 , 19 21 , 33 , 34 , 36 40 , 42 47 ] (Tables 1 , 2 and 3 ; Fig. 5 ).…”
Section: Resultsmentioning
confidence: 99%